BioSpace News Archive

North Sur Resources and Mindset Pharma Announce Proposed Transaction to Accelerate Development of Medical Psychedelics Industry

North Sur Resources Inc. and Mindset Pharma Inc. are pleased to announce that they have signed a binding letter of intent to combine their corporate entities.

June 29, 2020
·
9 min read
Business

BioMarin Promotes Company Veteran, Brian R. Mueller, to Executive Vice President, CFO

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced the promotions of Brian R. Mueller to Executive Vice President, Chief Financial Officer and of Andrea L. Acosta to Group Vice President, Chief Accounting Officer.

June 29, 2020
·
5 min read
Pharm Country

Cellectis S.A. Reports Results from Annual Shareholders’ General Meeting Held on June 29, 2020

Cellectis S.A. held its Annual Shareholders’ General Meeting (Euronext Growth: ALCLS – Nasdaq: CLLS) on June 29, 2020 at its head office in Paris, France.

June 29, 2020
·
1 min read
Business

Arvinas Appoints Wendy Dixon, Ph.D., to its Board of Directors

Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation, today announced that Wendy Dixon, Ph.D., has joined its Board of Directors.

June 29, 2020
·
2 min read
Pharm Country

OmniSeq Offers Differentiating Platform to Clinically Detect Rare Genetic Alterations to Identify Patients Eligible for New, Targeted Therapy for Lung and Thyroid Cancer

OmniSeq®, an innovator in next generation sequencing (NGS) in oncology, today announced the benefits of its OmniSeq Advance® comprehensive genomic and immune profiling assay to detect the presence of rare alterations in the RET gene in the tumors of some patients with non-small cell lung cancer (NSCLC) and thyroid cancer

June 29, 2020
·
3 min read
Business

MedMira Reports Third Quarter Results FY2020

MedMira Inc. (MedMira) (TSXV: MIR), reported today on its financial results for the quarter ended April 30, 2020.

June 29, 2020
·
3 min read
Business

The University of Texas Health Science Center at Houston joins Biomerica’s InFoods® Irritable Bowel Syndrome (“IBS”) Diagnostic-Guided Therapy (“DGT”) clinical trial

Biomerica Inc. (NASDAQ: BMRA) today announced it has signed a definitive agreement with the University of Texas Health Science Center at Houston (“UTH”) to join the clinical trial for Biomerica’s new InFoods® diagnostic-guided therapy, designed to alleviate Irritable Bowel Syndrome (IBS) symptoms.

June 29, 2020
·
8 min read
Policy

Alterity Therapeutics meeting with US FDA provides development pathway for ATH434

Alterity Therapeutics is pleased to announce that it has received guidance from the US Food and Drug Administration in relation to the development pathway for ATH434, the company’s lead compound for the treatment of Multiple System Atrophy, a Parkinsonian disorder.

June 29, 2020
·
2 min read
Business

Aran Biomedical Teoranta Announces the Appointment of Todd Blair to the Newly Created Role of VP Sales & Business Development (US)

Aran Biomedical, a trusted partner in the design, development and manufacture of implantable medical devices is pleased to announce the appointment of Mr. Todd Blair as Vice President of Sales and Business Development (US), with effect 1 st July 2020 . This role has been created to meet and manage the growing demand for Aran Bi

June 29, 2020
·
1 min read
Business

Sabar Health and Vaica Medical Announce Collaboration to Offer Digitally Connected Patient Support Services for Home Hospitalizations

Sabar Health is the largest home hospital service in Israel and is considered the largest physician-based home hospital in the world, caring for 7,000 patients yearly. Vaica is a global technology leader in the field of medication adherence, providing a Digital Patient Support Platform (DPSP) coupled with Medication Managemen

June 29, 2020
·
2 min read